Navigation Links
DNA Analysis Could Help Customize Treatments for MS
Date:1/16/2008

Study suggests it could show who will respond best to interferon beta treatments

WEDNESDAY, Jan. 16 (HealthDay News) -- Genetic differences might explain why some multiple sclerosis (MS) patients respond to treatment while others don't, suggests an international study.

Starting with 206 southern European patients with relapsing-remitting MS, the most common form of the disease, the researchers compared the DNA of patients whose symptoms were reduced by interferon beta therapy to the DNA of those who experienced relapses after such therapy. They were able to identify important genetic differences between the two groups of patients.

Those differences could eventually be used to help predict which MS treatments will benefit which patients, the study authors said. MS is a neurological disorder in which nerve fiber coatings degenerate, which leads to muscle weakness and possible paralysis.

The findings appeared in the Jan. 14 online issue of the Archives of Neurology and were expected to be published in the March print issue of the journal.

"The beneficial outcomes of interferon beta therapy for patients in the relapsing-remitting phase of MS have been clearly shown," the researchers wrote. "On the other hand, the effect of this treatment is partial, and a substantial amount of patients (up to 50 percent) are not responders. Hence, in the absence of prognostic clinical, neuroradiological and/or immunological markers of response, the question remains who and when to treat when adverse effects, inconvenience and the cost of drugs are significant."

More research is needed to fully predict MS treatment outcomes based on patient DNA analysis, the researchers added.

More information

The U.S. National Institute of Neurological Disorders and Stroke has more about MS.


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved

Page: 1 2

Related medicine news :

1. Congressional Budget Office Analysis of HR971 Rejects Pharmacy Benefit Managers Bogus Claim Bill Would Cost $29 Billion Over 5 Years
2. PCMA: New CBO Analysis Confirms Independent Pharmacy Collective Bargaining Legislation Increases Costs for Consumers and Payors
3. Working with children with autistic spectrum disorder: Psychoanalysis and neurobiology
4. Uses of medications in psychoanalysis
5. First rigorous analysis defines impact of Medicare Part D
6. Updated Analysis of 2001 Epoetin Alfa Study Posted
7. Biolytix to Offer Industrial Gene Expression Analysis and Genotyping Services Using Affymetrix GeneChip(R) Technology
8. Ranking Americas Mental Health: An Analysis of Depression Across the States
9. Amarin Announces Completion of Comprehensive Data Analysis From Phase III Huntingtons Disease Program
10. Long-term pharmacotherapy for obesity and overweight: updated meta-analysis
11. Center For Excellence to Fund Analysis of Michigan State Retiree Health Care Reforms
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... ... July 02, 2015 , ... Following the recent report by JAMA ... Americans outnumber merely overweight Americans, Samir Becic emphatically declared a war on obesity in ... right now," Becic said. "We must understand the magnitude of this discovery. For that ...
(Date:7/2/2015)... ... ... With summer in full swing, Americans are flocking to Canada’s many lakes to reel in ... in the world, and it’s easy to understand why. From the Pacific Northwest Coast of ... Recreational fishing is a huge industry, and Americans make up the vast majority of anglers ...
(Date:7/2/2015)... ... July 02, 2015 , ... ... of the SIGVARIS PERFORMANCE SOCKS. Since the socks were first introduced, they have ... Their significant popularity has inspired four new, fun shades including: blue, lime, pink ...
(Date:7/2/2015)... ... July 02, 2015 , ... ActiveBunch.com recently launched as a social network ... to function as a lifestyle community, Active Bunch allows users to connect with like-minded ... and participate in discussions or group events. , The spokesperson for Active Bunch ...
(Date:7/2/2015)... ... July 02, 2015 , ... ... that it has reached an agreement to acquire eRubbermaid.com, an Internet retailer ... of Rubbermaid Commercial Products on the web today. , “eRubbermaid.com’s ...
Breaking Medicine News(10 mins):Health News:Samir Becic's Health Fitness Revolution Declares War Against Obesity in America 2Health News:Samir Becic's Health Fitness Revolution Declares War Against Obesity in America 3Health News:Samir Becic's Health Fitness Revolution Declares War Against Obesity in America 4Health News:SIGVARIS is Sporting Four Brand New Colors in the Popular PERFORMANCE SOCK Product Line 2Health News:ActiveBunch.com Launches as a Social Community for People with Active Lifestyles 2Health News:CleanItSupply.com Acquires eRubbermaid.com 2
... HealthDay Reporter , MONDAY, May 21 (HealthDay News) ... to colonoscopies that don,t require sedation -- are effective ... the procedure lowered the risk of getting a colon ... dying from the disease by 26 percent, the researchers ...
... , MONDAY, May 21 (HealthDay News) -- Heart damage can be ... disease, a small, preliminary study found. Obesity is a risk ... adults have damage to their hearts. In the new study, ... 32 lean, 33 overweight and 32 obese -- with no symptoms ...
... HealthDay Reporter , MONDAY, May 21 (HealthDay News) -- In a ... high decibels on their MP3 players were also more likely than ... at concerts and clubs were more likely to drink heavily and ... don,t prove that loud music or concerts have anything to do ...
... a new technique for reconstructing the larynx after surgery ... of Otology, Rhinology and Laryngology , they describe how ... donors to replace removed larynx tissue allowed patients ... swallowing function with no need for immunosuppressive medications. ...
... quality of care you receive be affected by how your ... at Brigham and Women,s Hospital (BWH), doctors who dictated their ... who used structured documentation. The study is published ... Association . The researchers evaluated 18,569 visits by 7,000 ...
... Having so-called intensivist physicians on staff in intensive care units ... do not have similar coverage during the day, according to ... who specializes in the care of critically ill patients. ICUs ... day are referred to as high-intensity, while those with optional ...
Cached Medicine News:Health News:Study Supports Value of Sigmoidoscopy, an Alternative to Colonoscopy 2Health News:Obese Teens Can Have Heart Damage Without Showing Signs 2Health News:Teens' Love of Loud Music Tied to Drinking, Drug Abuse 2Health News:Donor aortic graft improves reconstruction after partial laryngectomy 2Health News:To dictate or not to dictate? 2Health News:Night Staffing With Critical Care Docs May Lower ICU Death Rates 2
(Date:7/2/2015)... OXFORD, England , July 2, 2015 ... commonly known as ,Friendly Aedes aegypti , ... of Juazeiro, Brazil by 95%, ...      (Logo: http://photos.prnewswire.com/prnh/20150630/227348LOGO) , The ... of a trial of Oxitec,s genetically engineered mosquitoes. The ...
(Date:7/2/2015)...   EVO Aesthetic Center and Wellness Spa ... aesthetics in Lakeway, Texas and ... Astanza Duality laser. The medical spa is focused on ... and laser procedures. Their addition of the Astanza Duality ... to their tattoo regret. "The large number ...
(Date:7/2/2015)... DURHAM, N.C. , July 2, 2015 ... of assets related to the ion channel biology platform ... previously been obtained as part of Pfizer,s 2011 acquisition ... Pfizer,s rights to the "Icagen" name and trademark.  XRPro ... comprehensive services for ion channel and transporter drug discovery, ...
Breaking Medicine Technology:Oxitec Mosquito Works to Control Aedes aegypti in Dengue Hotspot 2Oxitec Mosquito Works to Control Aedes aegypti in Dengue Hotspot 3EVO Offers Advanced Laser Tattoo Removal With Astanza Duality In Lakeway, TX 2Icagen Re-launched through XRpro Sciences Acquisition of Pfizer Team and Technology for Ion Channel and Transporter Drug R&D 2Icagen Re-launched through XRpro Sciences Acquisition of Pfizer Team and Technology for Ion Channel and Transporter Drug R&D 3Icagen Re-launched through XRpro Sciences Acquisition of Pfizer Team and Technology for Ion Channel and Transporter Drug R&D 4
... DUBLIN, Feb. 25, 2011 Warner Chilcott plc (Nasdaq: ... the quarter and year ended December 31, 2010. As discussed ... operations in the quarter ended December 31, 2010 as compared ... several important transactions in 2009 and 2010. These transactions ...
... 25, 2011 Western Digital ® ... has established a research and development center in Singapore, ... and expertise of research organizations, such as Singapore,s ... the development of advanced hard drive technologies.  Located in ...
Cached Medicine Technology:Warner Chilcott Reports Operating Results for the Quarter and Year Ended December 31, 2010 2Warner Chilcott Reports Operating Results for the Quarter and Year Ended December 31, 2010 3Warner Chilcott Reports Operating Results for the Quarter and Year Ended December 31, 2010 4Warner Chilcott Reports Operating Results for the Quarter and Year Ended December 31, 2010 5Warner Chilcott Reports Operating Results for the Quarter and Year Ended December 31, 2010 6Warner Chilcott Reports Operating Results for the Quarter and Year Ended December 31, 2010 7Warner Chilcott Reports Operating Results for the Quarter and Year Ended December 31, 2010 8Warner Chilcott Reports Operating Results for the Quarter and Year Ended December 31, 2010 9Warner Chilcott Reports Operating Results for the Quarter and Year Ended December 31, 2010 10Warner Chilcott Reports Operating Results for the Quarter and Year Ended December 31, 2010 11Warner Chilcott Reports Operating Results for the Quarter and Year Ended December 31, 2010 12Warner Chilcott Reports Operating Results for the Quarter and Year Ended December 31, 2010 13Warner Chilcott Reports Operating Results for the Quarter and Year Ended December 31, 2010 14Warner Chilcott Reports Operating Results for the Quarter and Year Ended December 31, 2010 15Warner Chilcott Reports Operating Results for the Quarter and Year Ended December 31, 2010 16Warner Chilcott Reports Operating Results for the Quarter and Year Ended December 31, 2010 17Warner Chilcott Reports Operating Results for the Quarter and Year Ended December 31, 2010 18Warner Chilcott Reports Operating Results for the Quarter and Year Ended December 31, 2010 19Warner Chilcott Reports Operating Results for the Quarter and Year Ended December 31, 2010 20Warner Chilcott Reports Operating Results for the Quarter and Year Ended December 31, 2010 21WD® Establishes Hard Drive R&D Center in Singapore 2WD® Establishes Hard Drive R&D Center in Singapore 3WD® Establishes Hard Drive R&D Center in Singapore 4
Ad-Techs Spinal Electrodes are intended for intraoperative monitoring of Evoked Potentials (EPs) of the descending pathway during spinal surgery. They are offered with 2 or 3 platinum contacts....
State-of-the-art sleep recording and analysis...
... TrueView Digital Mammography has been FDA approved, ... cancer detection. It is the first and ... diagnostic resolution - the highest available. SenoScan's ... Its curved breast support is more comfortable ...
Sphenoidal electrodes provide a less invasive method of recording brain activity in the epilepsy patient. Like all Integra Epilepsy electrodes, sphenoidal electrodes are fabricated from implant-grade...
Medicine Products: